-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2023 to Q4 2024.
- Tarsus Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2024 was $240K, a 80.5% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $540K, a 306% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $540K, a 306% increase from 2023.
- Tarsus Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $133K.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)